Effects of early rolipram treatment on histopathological outcome after controlled cortical impact injury in mice

Coleen M Atkins, Maria L. Cepero, Yuan Kang, Daniel J Liebl, W. Dalton Dietrich

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Traumatic brain injury (TBI) pathology includes contusions, cavitation, cell death, all of which can be exacerbated by inflammation. We hypothesized that an anti-inflammatory drug, rolipram, may reduce pathology after TBI, since in several CNS injury models rolipram reduces inflammation and improves cell survival and functional recovery. Adult male C57BL/6 mice received a craniotomy over the right parietotemporal cortex. Vertically directed controlled cortical impact (CCI) injury was delivered. Naïve controls were used for comparison. At 30 min post-surgery, animals were treated with vehicle or rolipram (1 mg/kg), and then once per day for 3 days. On day 3, the brains were systematically sectioned and stained to visualize the resulting pathology using hematoxylin and eosin (H & E) staining and NeuN immunocytochemistry. Total parietotemporal cortical contusion and cavity volume were significantly increased in rolipram-treated as compared to vehicle-treated CCI animals. Contusion areas at specific bregma levels indicated a significant effect of drug across bregma levels. Neuronal cell loss in the dentate hilus and area CA3 of the hippocampus were similar between vehicle and rolipram-treated animals. Although rolipram is well known to reduce pathology and inflammation in several other CNS injury models, the pathology resulting from CCI was worsened with rolipram at this particular dose and administration schedule. These studies suggest that consideration of the unique characteristics of TBI pathology is important in the extrapolation of promising therapeutic interventions from other CNS injury models.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalNeuroscience Letters
Volume532
Issue number1
DOIs
StatePublished - Jan 4 2013

Fingerprint

Rolipram
Pathology
Wounds and Injuries
Contusions
Inflammation
Therapeutics
Craniotomy
Hematoxylin
Eosine Yellowish-(YS)
Inbred C57BL Mouse
Pharmaceutical Preparations
Hippocampus
Cell Survival
Appointments and Schedules
Cell Death
Anti-Inflammatory Agents
Immunohistochemistry
Staining and Labeling
Brain

Keywords

  • Cyclic AMP,Contusion,Controlled cortical impact,Mice,Phosphodiesterase Rolipram

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Effects of early rolipram treatment on histopathological outcome after controlled cortical impact injury in mice. / Atkins, Coleen M; Cepero, Maria L.; Kang, Yuan; Liebl, Daniel J; Dalton Dietrich, W.

In: Neuroscience Letters, Vol. 532, No. 1, 04.01.2013, p. 1-6.

Research output: Contribution to journalArticle

@article{b9845395334b43c6b89ce12949a9fd35,
title = "Effects of early rolipram treatment on histopathological outcome after controlled cortical impact injury in mice",
abstract = "Traumatic brain injury (TBI) pathology includes contusions, cavitation, cell death, all of which can be exacerbated by inflammation. We hypothesized that an anti-inflammatory drug, rolipram, may reduce pathology after TBI, since in several CNS injury models rolipram reduces inflammation and improves cell survival and functional recovery. Adult male C57BL/6 mice received a craniotomy over the right parietotemporal cortex. Vertically directed controlled cortical impact (CCI) injury was delivered. Na{\"i}ve controls were used for comparison. At 30 min post-surgery, animals were treated with vehicle or rolipram (1 mg/kg), and then once per day for 3 days. On day 3, the brains were systematically sectioned and stained to visualize the resulting pathology using hematoxylin and eosin (H & E) staining and NeuN immunocytochemistry. Total parietotemporal cortical contusion and cavity volume were significantly increased in rolipram-treated as compared to vehicle-treated CCI animals. Contusion areas at specific bregma levels indicated a significant effect of drug across bregma levels. Neuronal cell loss in the dentate hilus and area CA3 of the hippocampus were similar between vehicle and rolipram-treated animals. Although rolipram is well known to reduce pathology and inflammation in several other CNS injury models, the pathology resulting from CCI was worsened with rolipram at this particular dose and administration schedule. These studies suggest that consideration of the unique characteristics of TBI pathology is important in the extrapolation of promising therapeutic interventions from other CNS injury models.",
keywords = "Cyclic AMP,Contusion,Controlled cortical impact,Mice,Phosphodiesterase Rolipram",
author = "Atkins, {Coleen M} and Cepero, {Maria L.} and Yuan Kang and Liebl, {Daniel J} and {Dalton Dietrich}, W.",
year = "2013",
month = "1",
day = "4",
doi = "10.1016/j.neulet.2012.10.019",
language = "English",
volume = "532",
pages = "1--6",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Effects of early rolipram treatment on histopathological outcome after controlled cortical impact injury in mice

AU - Atkins, Coleen M

AU - Cepero, Maria L.

AU - Kang, Yuan

AU - Liebl, Daniel J

AU - Dalton Dietrich, W.

PY - 2013/1/4

Y1 - 2013/1/4

N2 - Traumatic brain injury (TBI) pathology includes contusions, cavitation, cell death, all of which can be exacerbated by inflammation. We hypothesized that an anti-inflammatory drug, rolipram, may reduce pathology after TBI, since in several CNS injury models rolipram reduces inflammation and improves cell survival and functional recovery. Adult male C57BL/6 mice received a craniotomy over the right parietotemporal cortex. Vertically directed controlled cortical impact (CCI) injury was delivered. Naïve controls were used for comparison. At 30 min post-surgery, animals were treated with vehicle or rolipram (1 mg/kg), and then once per day for 3 days. On day 3, the brains were systematically sectioned and stained to visualize the resulting pathology using hematoxylin and eosin (H & E) staining and NeuN immunocytochemistry. Total parietotemporal cortical contusion and cavity volume were significantly increased in rolipram-treated as compared to vehicle-treated CCI animals. Contusion areas at specific bregma levels indicated a significant effect of drug across bregma levels. Neuronal cell loss in the dentate hilus and area CA3 of the hippocampus were similar between vehicle and rolipram-treated animals. Although rolipram is well known to reduce pathology and inflammation in several other CNS injury models, the pathology resulting from CCI was worsened with rolipram at this particular dose and administration schedule. These studies suggest that consideration of the unique characteristics of TBI pathology is important in the extrapolation of promising therapeutic interventions from other CNS injury models.

AB - Traumatic brain injury (TBI) pathology includes contusions, cavitation, cell death, all of which can be exacerbated by inflammation. We hypothesized that an anti-inflammatory drug, rolipram, may reduce pathology after TBI, since in several CNS injury models rolipram reduces inflammation and improves cell survival and functional recovery. Adult male C57BL/6 mice received a craniotomy over the right parietotemporal cortex. Vertically directed controlled cortical impact (CCI) injury was delivered. Naïve controls were used for comparison. At 30 min post-surgery, animals were treated with vehicle or rolipram (1 mg/kg), and then once per day for 3 days. On day 3, the brains were systematically sectioned and stained to visualize the resulting pathology using hematoxylin and eosin (H & E) staining and NeuN immunocytochemistry. Total parietotemporal cortical contusion and cavity volume were significantly increased in rolipram-treated as compared to vehicle-treated CCI animals. Contusion areas at specific bregma levels indicated a significant effect of drug across bregma levels. Neuronal cell loss in the dentate hilus and area CA3 of the hippocampus were similar between vehicle and rolipram-treated animals. Although rolipram is well known to reduce pathology and inflammation in several other CNS injury models, the pathology resulting from CCI was worsened with rolipram at this particular dose and administration schedule. These studies suggest that consideration of the unique characteristics of TBI pathology is important in the extrapolation of promising therapeutic interventions from other CNS injury models.

KW - Cyclic AMP,Contusion,Controlled cortical impact,Mice,Phosphodiesterase Rolipram

UR - http://www.scopus.com/inward/record.url?scp=84871035112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871035112&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2012.10.019

DO - 10.1016/j.neulet.2012.10.019

M3 - Article

VL - 532

SP - 1

EP - 6

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1

ER -